Rigel Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Rigel Pharmaceuticals Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Rigel Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Rigel Pharmaceuticals Inc.

Back to companies

Rigel Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Rigel Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Rigel Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Gregg A. Lapointe

Chairman Executive Board Since: 2017 Age: 67

Mr. Gregg A. Lapointe has been the Chairman of the company since 2022. Prior to this, he served as the Chief Executive Officer and co-founder of Cerium Pharmaceuticals Inc. Previously, he served as the Chief Executive Officer of Sigma-Tau Pharmaceuticals Inc (now Leadiant Biosciences Inc).

Read Hide full bio of Gregg A. Lapointe

Raul R. Rodriguez

Director; President; Chief Executive Officer Executive Board Since: 2014 Age: 65

Mr. Raul R. Rodriguez has been the Chief Executive Officer, Director, and President of the company since 2014. Prior to this, he served as the President and Chief Operating Officer of the company. Previously, he served as the Vice President of Business Development of the company. Mr. Rodriguez also served as the Senior Vice President of Business Development and Operations at Curis (formerly, Ontogeny); Executive Director of Business Development and Market Planning at Scios; held various positions at G.D. Searle & Company.

Read Hide full bio of Raul R. Rodriguez

Dean L. Schorno

Chief Financial Officer; Executive Vice President Senior Management Since: 2018 Age: 63

Mr. Dean L. Schorno has been the Executive Vice President and Chief Financial Officer of the company since 2018. Prior to this, he served as the Chief Financial Officer at 23andMe Inc. Mr. Schorno also served as the Chief Financial Officer at Adaptive Biotechnologies (Seattle, WA) and Genomic Health (Redwood City, CA).

Read Hide full bio of Dean L. Schorno

Raymond J. Furey

General Counsel; Secretary; Chief Compliance Officer; Executive Vice President Senior Management Since: 2023 Age: 58

Mr. Raymond J. Furey has been the Executive Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer of the company since 2023. Prior to this, he served as the Senior Vice President and Chief Compliance Officer at Turning Point Therapeutics. Previously, he served as the Chief Operating Officer at Ara Pharmaceuticals.

Read Hide full bio of Raymond J. Furey

David A. Santos

Executive Vice President; Chief Commercial Officer Senior Management Since: 2020 Age: 63

Mr. David A. Santos has been the Executive Vice President and Chief Commercial Officer of the company since 2020. Prior to this, he served as the Head of hematology/oncology business unit head of Jazz Pharmaceuticals. Previously, he served as the Vice President of sales and marketing for Medivation (now Pfizer). Mr. Santos also served as the Vice President, kinase inhibitor franchise for Onyx (now Amgen).

Read Hide full bio of David A. Santos
Gain a 360-degree view of Rigel Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Rigel Pharmaceuticals Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer